News and Trends 10 Oct 2022 Chinese company sees approval for diabetes drug Hua Medicine says its new drug application (NDA) for HuaTangNing (dorzagliatin tablets) has been approved by the National Medical Products Administration (NMPA) in China. HuaTangNing is a first-in-class glucokinase activator (GKA) developed by the company. The approval is for two indications, both to improve blood glucose control for type 2 diabetes (T2D) patients, as monotherapy […] October 10, 2022 - 6 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 10 Oct 2022 Saudi university study could pave way for new cancer drugs Precise details of how a master regulator of gene expression binds its activating partner could open new avenues for cancer drug development. The findings were made at the King Abdullah University Of Science And Technology in Saudi Arabia. They reveal how the activating partner, a small cellular metabolite and signaling molecule called PI5P, interacts simultaneously […] October 10, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2022 AI model study may lead to identifying skin cancer from blood test Researchers have developed an artificial intelligence (AI) model that predicts which skin cancer patients will benefit from a treatment that activates the immune defense system. The scientists are from the University of Helsinki, HUS Comprehensive Cancer Center, Aalto University and Stanford University. In practice, the AI model makes it possible to diagnose skin cancer with […] October 7, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Oct 2022 Needle-free diabetes care: 7 devices that painlessly monitor blood sugar Will the daily routine of finger pricking to monitor blood sugar levels finally come to an end for the millions living with diabetes? Diabetes affects over 537 million adults worldwide. People with diabetes have to test their blood sugar levels several times a day, usually by pricking their finger with a lancet. This can be […] October 7, 2022 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2022 Japanese scientists find way to detect characteristic of Alzheimer’s disease from blood samples Researchers from Hokkaido University in Japan and Toppan have developed a method to detect build-up of amyloid β in the brain, a characteristic of Alzheimer’s disease, from biomarkers in blood samples. Alzheimer’s disease is a neurodegenerative disease, characterized by a gradual loss of neurons and synapses in the brain. One of the primary causes of […] October 7, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2022 Scientists at IRB Barcelona and PCCB create study model for Ewing sarcoma Ewing sarcoma is the second most frequent bone tumor in children, adolescents, and young adults. There is no specific treatment for this disease and current management is still limited to surgery, radiotherapy, and chemotherapy. The long-term survival of patients with metastatic or relapsed Ewing sarcoma is very low. Ewing sarcoma is caused by a single […] October 7, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2022Beyond Biotech podcast 17: BIO-Europe, National Hemophilia Foundation This week, we have three interviews. Our guests are: Pam Putz, managing director of EBD Group EU; André Hofmann, CEO of biosaxony; and Kevin Mills, chief scientific officer at the National Hemophilia Foundation and Teri Willey, managing director of the National Hemophilia Foundation’s Pathway to Cures. We also have our weekly chat with global commercial […] October 7, 2022 Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2022 GATC AI platform reduces time to find opioid use disorder candidates GATC Health says the new drug candidates discovered by its proprietary AI drug discovery and prediction platform to treat opioid use disorder (OUD) and fentanyl addiction have entered pre-clinical development. GATC is partnering with Christie D. Fowler at the University of California, Irvine (UCI) and global scientific testing company, Eurofins Discovery, for the pre-clinical programs […] October 7, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2022 Promising results for methamphetamine addiction treatment Addiction Cure Therapeutic Sciences Inc., a biotech company targeting drug and alcohol addiction cures and treatments, has announced results from its epigenetic testing. Data from the mouse models in-lab testing indicates a lead HDAC (histone deacetylases) inhibitor can modulate the behavioral effects of methamphetamine, promoting sustained protection, despite repeated exposure to methamphetamine. If successful, this […] October 7, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2022 Mission Bio launches first commercial high-throughput cell therapy assay for measuring vector copy number Mission Bio has announced the availability of the Tapestri VCN Assay, the first high-throughput commercial single-cell assay to simultaneously quantify vector copy number (VCN) and transduction at the level of individual cells. For the first time, developers of cell therapies like CAR-T cells will be able to apply multi-omic analysis to assess the cell-to-cell variability […] October 7, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2022 Ziphius and UZ Ghent collaborating on manufacture of saRNA-based vaccines Ziphius Vaccines, a biopharmaceutical company developing vaccines and therapeutics based on self-amplifying RNA (saRNA), and UZ Ghent have entered a public-private collaboration for the scale up and manufacturing of prophylactic self-amplifying RNA vaccines based on GMP (good manufacturing practice) standards. The collaboration is a first in Europe where a university hospital produces GMP grade prophylactic […] October 7, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 6 Oct 2022 Growing hub Lithuania ready to welcome biotech sector to EFIB’22 On October 26 and 27 the Lithuanian capital, Vilnius, is hosting the European Forum for Industrial Biotechnology & the Bioeconomy 2022 (EFIB’22). EFIB, one of Europe’s top biotech events, will bring together business leaders, entrepreneurs, scientists, and investors. Executive director of the Lithuanian Biotechnology Association, Agnė Vaitkevičienė, explains the importance of EFIB and the potential […] October 6, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email